Skip to content

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease

Study of Symptoms Related to the Lesion Effect Associated With the Implantation of Electrodes for Stimulation of the Subthalamic Nuclei in the Treatment of Parkinson's Disease.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06389903
Acronym
PSYLES-STIM
Enrollment
15
Registered
2024-04-29
Start date
2019-06-04
Completion date
2021-10-05
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Brain stimulation

Brief summary

This is a pilot, prospective, monocentric study concerning 15 Parkinson's disease patients requiring deep brain stimulation implantation. The primary objective is to evaluate the psychiatric lesion effects of deep brain stimulation in patients with Parkinson's disease, using the Young Mania Rating Scale (YMRS), Big Five Inventory and the Hamilton Depression Rating Scale (HAMD 21).

Detailed description

The patients included were adults suffering from Parkinson's disease (according to ICD-10). They had no severe psychiatric disorders, and no major neurocognitive disorders contraindicating surgery. An initial evaluation will be carried out 72 hours after surgery, then after one month, and finally 3 months after surgery.

Interventions

BEHAVIORALassessment

post-surgery behavioral assessment using scales

Sponsors

Centre Hospitalier du Rouvray
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patient * Diagnosis of Parkinson's disease (ICD-10) * L-dopa test must be positive * Participants who gave their informed, written consent

Exclusion criteria

* Severe psychiatric disorder * Major neurocognitive disorder contraindicating surgery

Design outcomes

Primary

MeasureTime frameDescription
Assessment of change of mania symptomsBaseline, 72 hours, 1 month and 3 months after surgeryThe variation of Young Mania Rating Scale (YMRS). The YMRS total score ranges from 0 to 60 where higher scores indicate more severe mania.

Secondary

MeasureTime frameDescription
Assessment of change of BehaviorBaseline, 72 hours, 1 month and 3 months after surgeryThe variation of the Ardouin Scale of Behavior in Parkinson's Disease. The total score ranges from 0 to 84. Higher score mean worse outcome.
Assessment of change of ImpulsivityBaseline, 72 hours, 1 month and 3 months after surgeryThe variation of the Dickman Impulsivity Inventory. It is a self report measure assessing dysfunctional impulsivity and functional impulsivity. Regarding dysfunctional impulsivity (12 items), higher score mean worse adaptation. Regarding functional impulsivity (11 items), higher score mean better adaptation.
Assessment of change of ApathyBaseline, 72 hours, 1 month and 3 months after surgeryThe variation of the Apathy Evaluation Scale. This 18 item scale ranges from 0 to 12. Higher score means worse outcome.
Assessment of change of depressive symptomsBaseline, 72 hours, 1 month and 3 months after surgeryThe variation of Hamilton Rating Scale for Depression (HAMD-21). HAMD21 is a 21-item assessment used to measure depression severity. Items were rated on a scale from 0 (symptoms not present) to a maximum of 2 to 4 (symptom extremely severe) for a total score ranging from 0 (not at all depressed) to 64 (severely depressed).
Assessment of executive functionsBaseline, 72 hours, 3 months after surgeryFrontal Assessment Battery at Bedside. Thebattery consists of six subtests exploring the following: conceptualization, mental flexibility, motor programming, sensitivity to interference, inhibitory control, and environmental autonomy.
Assessment of confusion72 hours and 3 months after surgeryConfusion Assessment method (CAM). The CAM instrument assesses the presence, severity, and fluctuation of 9 delirium features: acute onset, inattention, disorganized thinking, altered level of consciousness, disorientation, memory impairment, perceptual disturbances, psychomotor agitation or retardation, and altered sleep-wake cycle.
Assessment of personalityBaselineBig Five inventory. The test identified five factors as follows : * openness to experience (inventive/curious vs. consistent/cautious) * conscientiousness (efficient/organized vs. extravagant/careless) * extraversion (outgoing/energetic vs. solitary/reserved) * agreeableness (friendly/compassionate vs. critical/judgmental) * neuroticism (sensitive/nervous vs. resilient/confident)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026